Colorectal, Cancer Clinical Trials in Nanjing, Jiangsu
5 recruitingNanjing, Jiangsu, China
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer
Colorectal, CancerPancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School49 enrolled1 locationNCT07353645
Recruiting
Early Phase 1
Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Third-line Treatment for Advanced Colorectal Cancer.
Colorectal, CancerDC-CIK TreatmentRegorafenib+2 more
JIANG LONGWEI14 enrolled1 locationNCT07343791
Recruiting
Phase 2
Nocardia Rubra Cell Wall Skeleton in Combination With Prior Second- or Third-line Regimens for the Treatment of Potentially Hazardous Colorectal Cancer SD Status
Colorectal, CancerColorectal Neoplasms
Sun Jing22 enrolled1 locationNCT06356714
Recruiting
Phase 4
Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine Monotherapy
Colorectal, Cancer
Fudan University756 enrolled9 locationsNCT06090994
Recruiting
Phase 2
Fluorouracil Treatment Via Colon for Colorectal Cancer
Colorectal, Cancer
The Second Hospital of Nanjing Medical University40 enrolled1 locationNCT06385418